Multiple Myeloma Pipeline Expands With 80+ Therapies as Treatment Paradigms Evolve
The multiple myeloma treatment landscape is rapidly expanding with over 75 companies developing 80+ pipeline therapies, while clinicians navigate evolving questions about transplant timing, quadruplet regimens, and minimal residual disease testing in newly diagnosed patients.